|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:approvalYear
|
1997
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
L02BG04
|
|
gptkbp:CASNumber
|
gptkb:88150-42-9
|
|
gptkbp:category
|
antineoplastic agent
nonsteroidal aromatase inhibitor
|
|
gptkbp:contraindication
|
pregnancy
pre-menopausal women
|
|
gptkbp:discoveredBy
|
gptkb:Ciba-Geigy
|
|
gptkbp:eliminationHalfLife
|
2 days
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
gptkbp:hasInChIKey
|
OBLPEUPLXAWFQQ-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C17H11N5
|
|
gptkbp:hasSMILES
|
N#Cc1ccc(cc1)Cn2nnc(n2)c3ccc(cc3)C#N
|
|
gptkbp:hasUNII
|
T6X3C9B8IV
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
88150-42-9
|
|
gptkbp:IUPACName
|
gptkb:4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
285.31 g/mol
|
|
gptkbp:name
|
gptkb:Letrozole
|
|
gptkbp:PubChem_CID
|
3768
3902
CHEMBL716
DB01006
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
fatigue
joint pain
hot flashes
|
|
gptkbp:synonym
|
gptkb:Femara
|
|
gptkbp:usedAs
|
aromatase inhibitor
|
|
gptkbp:usedFor
|
treatment of breast cancer
|
|
gptkbp:bfsParent
|
gptkb:amlodipine
|
|
gptkbp:bfsLayer
|
6
|